Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O2RN
|
||||
Former ID |
DNC004507
|
||||
Drug Name |
N-(4-Methyl-benzoyl)-N'-phenethyl-guanidine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [526204] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H19N3O
|
||||
Canonical SMILES |
CC1=CC=C(C=C1)C(=O)NC(=NCCC2=CC=CC=C2)N
|
||||
InChI |
1S/C17H19N3O/c1-13-7-9-15(10-8-13)16(21)20-17(18)19-12-11-14-5-3-2-4-6-14/h2-10H,11-12H2,1H3,(H3,18,19,20,21)
|
||||
InChIKey |
ZVURELUSYUBEQF-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium channel protein type 5 subunit alpha | Target Info | Inhibitor | [526204] | |
KEGG Pathway | Adrenergic signaling in cardiomyocytes | ||||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
Reactome | Interaction between L1 and Ankyrins | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.